Wellington Partners

HepaRegeniX GmbH is a biopharmaceutical company based in Ulm, Germany, founded in 2016. It specializes in developing innovative therapies for acute and chronic liver diseases, focusing on restoring the regenerative capacity of hepatocytes. The company’s therapeutic approach is based on research led by Professor Lars Zender at the University Hospital Tübingen, which identified mitogen-activated protein kinase kinase 4 (MKK4) as a critical regulator of liver regeneration. HepaRegeniX is developing small-molecule inhibitors of MKK4, aiming to enhance liver regeneration even in severely diseased conditions. The company’s potential treatments may address various liver disorders, including nonalcoholic steatohepatitis.

Aignostics GmbH is a Berlin-based company founded in 2018 that specializes in AI-powered diagnostics and pathology software solutions aimed at enhancing pharmaceutical research and clinical diagnostics. The company focuses on precision diagnostics, employing patented technology to reverse-engineer conventional AI systems, thereby addressing their “black-box” limitations. Aignostics' platform generates explainable diagnostic results presented as precise heatmaps and image overlays, which facilitate the verification process for pathologists. This capability is crucial in ensuring accurate diagnoses, particularly in the context of discovering and validating biomarkers for cancer and other complex diseases. By improving the understanding of tissue-based biomarkers, Aignostics aims to significantly advance the diagnosis and treatment of various conditions, thereby supporting the broader goals of precision medicine and drug development.

Sphingotec GmbH, established in 2002 and based in Brandenburg, Germany, specializes in developing blood-based protein biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions. These conditions include acute heart failure, acute kidney injury, and circulatory shock. The company's portfolio also extends to developing monoclonal antibody therapies in combination with targeted diagnostic tests, aiming to improve the management and recovery of critically ill patients.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Nyra Health is a company founded in 2020 and headquartered in Vienna, Austria, that specializes in artificial intelligence and evidence-based neurological research. It has developed a digital therapy platform aimed at addressing personal neurological deficits, which can be utilized in both clinical settings and at home using internet protocol adapters or mobile devices. This innovative platform provides a unique form of therapy grounded in scientific principles, allowing patients to maximize their rehabilitation potential regardless of time or location. Nyra Health's approach signifies a significant advancement in the field of digital rehabilitation, making therapeutic interventions more accessible and personalized for individuals with neurological challenges.

Orcan Energy AG, founded in 2008 and based in Munich, Germany, specializes in developing, manufacturing, and selling energy solutions that convert waste heat into electricity using Organic Rankine Cycle (ORC) technology. The company's products, such as the PACK 20.30 and PACK 05.15 modules, are designed to reuse waste heat from various sources including industrial processes, traffic, and distributed energy conversion. These solutions have applications in marine, biogas, mobile applications like trucks, buses, construction machinery, and power generation. Orcan Energy's technology is known for its efficiency and ease of use, with innovations that make it suitable for mass market adoption. The company operates as a subsidiary of E.ON SE.

Aignostics GmbH is a Berlin-based company founded in 2018 that specializes in AI-powered diagnostics and pathology software solutions aimed at enhancing pharmaceutical research and clinical diagnostics. The company focuses on precision diagnostics, employing patented technology to reverse-engineer conventional AI systems, thereby addressing their “black-box” limitations. Aignostics' platform generates explainable diagnostic results presented as precise heatmaps and image overlays, which facilitate the verification process for pathologists. This capability is crucial in ensuring accurate diagnoses, particularly in the context of discovering and validating biomarkers for cancer and other complex diseases. By improving the understanding of tissue-based biomarkers, Aignostics aims to significantly advance the diagnosis and treatment of various conditions, thereby supporting the broader goals of precision medicine and drug development.

iOmx Therapeutics AG is a Munich-based company specializing in immuno-oncology target discovery and drug development. The company focuses on creating first-in-class cancer therapeutics that target novel immune checkpoint modulators present on tumor cells. Utilizing a proprietary siRNA-based screening technology, iOmx systematically analyzes human tumor cells to identify innovative therapeutic targets and understand their mechanisms of action. The company's approach is rooted in the principles of cancer immune-checkpoint therapy, which aims to overcome tumors' inherent resistance to immune attacks. This resistance is often mediated by cell surface molecules that inhibit T cell activation. By neutralizing these negative interactions, iOmx Therapeutics seeks to reactivate the host immune response, ultimately enhancing the effectiveness of cancer treatments.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Adrenomed AG is a biopharmaceutical company based in Hennigsdorf, Germany, focused on developing monoclonal antibody therapies for critical conditions such as sepsis and acute heart failure. Founded in 2009, the company’s lead product candidate, Adrecizumab, is a novel humanized monoclonal antibody designed to target Adrenomedullin, a peptide hormone crucial for maintaining vascular integrity. This first-in-class treatment aims to address life-threatening situations characterized by vascular leakage and shock, offering a potential solution for patients with limited treatment options. Adrenomed employs a unique approach by combining its therapeutic antibody with a specific diagnostic tool that uses Adrenomedullin as a biomarker to identify suitable patients for treatment. The company holds a strong intellectual property position, with patents granted in major markets, ensuring its innovative therapies are well protected as they progress through clinical development.

Themis Bioscience N.V. is a clinical-stage biopharmaceutical company headquartered in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead product candidate, MV-CHIK, has completed Phase II clinical trials for chikungunya treatment. Themis is also engaged in developing vaccines for various health threats, including cancer, Zika virus, Lassa fever, and MERS. Themis leverages its advanced understanding of immune system mechanisms through its innovative vaccine platform, focusing on both emerging and specialized indications. The company has established research collaborations and exclusive licensing agreements to enhance its development capabilities, positioning itself as a strategic partner for leading biotechnology and pharmaceutical firms.

AMBOSS GmbH is a digital platform based in Cologne, Germany, that caters to the needs of medical students and physicians. Founded in 2012, the company develops and markets a comprehensive medical study platform that offers valuable resources such as study materials and a question bank. The platform is designed to deliver medical knowledge quickly and efficiently, supporting users in their educational and professional endeavors. Originally established as MIAMED GmbH, AMBOSS has positioned itself as a physician-driven resource, enhancing the learning experience for those in the medical field.

Adrenomed AG is a biopharmaceutical company based in Hennigsdorf, Germany, focused on developing monoclonal antibody therapies for critical conditions such as sepsis and acute heart failure. Founded in 2009, the company’s lead product candidate, Adrecizumab, is a novel humanized monoclonal antibody designed to target Adrenomedullin, a peptide hormone crucial for maintaining vascular integrity. This first-in-class treatment aims to address life-threatening situations characterized by vascular leakage and shock, offering a potential solution for patients with limited treatment options. Adrenomed employs a unique approach by combining its therapeutic antibody with a specific diagnostic tool that uses Adrenomedullin as a biomarker to identify suitable patients for treatment. The company holds a strong intellectual property position, with patents granted in major markets, ensuring its innovative therapies are well protected as they progress through clinical development.

Sphingotec GmbH, established in 2002 and based in Brandenburg, Germany, specializes in developing blood-based protein biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions. These conditions include acute heart failure, acute kidney injury, and circulatory shock. The company's portfolio also extends to developing monoclonal antibody therapies in combination with targeted diagnostic tests, aiming to improve the management and recovery of critically ill patients.

Themis Bioscience N.V. is a clinical-stage biopharmaceutical company headquartered in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead product candidate, MV-CHIK, has completed Phase II clinical trials for chikungunya treatment. Themis is also engaged in developing vaccines for various health threats, including cancer, Zika virus, Lassa fever, and MERS. Themis leverages its advanced understanding of immune system mechanisms through its innovative vaccine platform, focusing on both emerging and specialized indications. The company has established research collaborations and exclusive licensing agreements to enhance its development capabilities, positioning itself as a strategic partner for leading biotechnology and pharmaceutical firms.

Heliatek GmbH, founded in 2006 and based in Dresden, Germany, specializes in the development and manufacture of organic photovoltaics (OPV) solutions, particularly HeliaSol and HeliaFilm. These innovative products are designed for integration into various building surfaces, including horizontal, vertical, and curved structures, making them suitable for retrofitting existing buildings as well as for new construction. Heliatek's OPV technology is characterized by its ultra-lightweight and flexible nature, contributing to environmentally friendly energy solutions. The company serves a diverse clientele, including those in the building and construction materials industry, automotive manufacturers, and suppliers, and has established strategic partnerships with firms such as AGC Glass Europe and Reckli China. With approximately 160 employees, Heliatek is at the forefront of advancing organic electronics, utilizing advanced roll-to-roll manufacturing processes in controlled environments to produce its solar films.

Themis Bioscience N.V. is a clinical-stage biopharmaceutical company headquartered in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead product candidate, MV-CHIK, has completed Phase II clinical trials for chikungunya treatment. Themis is also engaged in developing vaccines for various health threats, including cancer, Zika virus, Lassa fever, and MERS. Themis leverages its advanced understanding of immune system mechanisms through its innovative vaccine platform, focusing on both emerging and specialized indications. The company has established research collaborations and exclusive licensing agreements to enhance its development capabilities, positioning itself as a strategic partner for leading biotechnology and pharmaceutical firms.

Heliatek GmbH, founded in 2006 and based in Dresden, Germany, specializes in the development and manufacture of organic photovoltaics (OPV) solutions, particularly HeliaSol and HeliaFilm. These innovative products are designed for integration into various building surfaces, including horizontal, vertical, and curved structures, making them suitable for retrofitting existing buildings as well as for new construction. Heliatek's OPV technology is characterized by its ultra-lightweight and flexible nature, contributing to environmentally friendly energy solutions. The company serves a diverse clientele, including those in the building and construction materials industry, automotive manufacturers, and suppliers, and has established strategic partnerships with firms such as AGC Glass Europe and Reckli China. With approximately 160 employees, Heliatek is at the forefront of advancing organic electronics, utilizing advanced roll-to-roll manufacturing processes in controlled environments to produce its solar films.

iOmx Therapeutics AG is a Munich-based company specializing in immuno-oncology target discovery and drug development. The company focuses on creating first-in-class cancer therapeutics that target novel immune checkpoint modulators present on tumor cells. Utilizing a proprietary siRNA-based screening technology, iOmx systematically analyzes human tumor cells to identify innovative therapeutic targets and understand their mechanisms of action. The company's approach is rooted in the principles of cancer immune-checkpoint therapy, which aims to overcome tumors' inherent resistance to immune attacks. This resistance is often mediated by cell surface molecules that inhibit T cell activation. By neutralizing these negative interactions, iOmx Therapeutics seeks to reactivate the host immune response, ultimately enhancing the effectiveness of cancer treatments.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

AMBOSS GmbH is a digital platform based in Cologne, Germany, that caters to the needs of medical students and physicians. Founded in 2012, the company develops and markets a comprehensive medical study platform that offers valuable resources such as study materials and a question bank. The platform is designed to deliver medical knowledge quickly and efficiently, supporting users in their educational and professional endeavors. Originally established as MIAMED GmbH, AMBOSS has positioned itself as a physician-driven resource, enhancing the learning experience for those in the medical field.

4SC is a clinical-stage biopharmaceutical company focused on discovering and developing targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases, particularly in areas with significant unmet medical needs. The company aims to offer innovative treatment options that enhance tolerability and efficacy, ultimately improving patients' quality of life. 4SC's drug development pipeline includes two clinical candidates, resminostat and Domatinostat, which are protected by a strong portfolio of patents. The company operates primarily in Germany and the European Union, while also generating revenue from various other countries.

ImevaX GmbH is a biopharmaceutical company based in Munich, Germany, founded in 2014. The company specializes in developing vaccines targeting pathogens that cause chronic infectious diseases and nosocomial infections. ImevaX's approach involves creating specific vaccines against immune evasion factors used by these pathogens to control infections. Their lead candidate is IMX 101, a vaccine designed to combat Helicobacter pylori, a bacterium that colonizes the stomach and is linked to ulcer disease and gastric cancer in humans. The company’s research focuses on understanding and neutralizing bacterial factors that down-regulate the host immune system, a mechanism used by many highly infectious pathogens. Additionally, ImevaX offers diagnostic tests for early detection of Helicobacter pylori infections.

Heliatek GmbH, founded in 2006 and based in Dresden, Germany, specializes in the development and manufacture of organic photovoltaics (OPV) solutions, particularly HeliaSol and HeliaFilm. These innovative products are designed for integration into various building surfaces, including horizontal, vertical, and curved structures, making them suitable for retrofitting existing buildings as well as for new construction. Heliatek's OPV technology is characterized by its ultra-lightweight and flexible nature, contributing to environmentally friendly energy solutions. The company serves a diverse clientele, including those in the building and construction materials industry, automotive manufacturers, and suppliers, and has established strategic partnerships with firms such as AGC Glass Europe and Reckli China. With approximately 160 employees, Heliatek is at the forefront of advancing organic electronics, utilizing advanced roll-to-roll manufacturing processes in controlled environments to produce its solar films.

AYOXXA Biosystems GmbH is a life science tools company based in Cologne, Germany, with additional offices in Singapore and Boston, Massachusetts. Founded in 2010, AYOXXA specializes in developing a proprietary technology platform for multiplexed protein analysis. This platform, which utilizes In-situ Encoded Bead-based Arrays, enables users to simultaneously measure multiple protein markers associated with various health conditions, including cancer, allergies, cardiovascular diseases, and infectious diseases. AYOXXA's innovative biochips merge biological analysis with information technology, expanding the potential applications in biomedical research. The company also offers biomarker kits to facilitate the identification and quantification of proteins and other biomolecular analytes.

Definiens is a provider of image analysis and data mining solutions specifically designed for quantitative digital pathology within the life sciences, diagnostic biomarkers, and healthcare sectors. The company's software delivers detailed insights from whole tissue slides, cell-based assays, and full body scans, enabling the integration of this information with data from various sources. By automating analysis workflows, Definiens enhances the capabilities of pharmaceutical and biotechnology companies, research institutions, clinical service organizations, and pathologists, facilitating informed decision-making in research, diagnostics, and therapy. Headquartered in Munich, Germany, with additional offices in the United States, Definiens aims to advance research, contribute to the development of personalized medicine, and improve patient outcomes.

Opvizor GmbH, founded in 2012 and based in Vienna, Austria, specializes in developing a cloud-based expert system that enhances the management of virtual IT infrastructures. The company's flagship product, Opvizor, is an agent-less Software-as-a-Service application that provides automated support by detecting potential configuration and operational issues within VMware environments. By analyzing protocol files, configuration, event, and performance data, Opvizor identifies system integrity concerns and strengthens security measures. The platform offers predictive insights, helping to prevent approximately 60% of costly support issues before they arise. With features such as a crowd-sourced knowledge base, automated error analysis, and comprehensive reporting, Opvizor enables IT administrators to maintain stability and optimize performance in their virtual environments, all while being operational in under ten minutes.

Dacuda is a computer vision company based in Zurich, Switzerland, with additional locations in Palo Alto, California, and Shanghai, China. It specializes in real-time 2D and 3D algorithms that enhance camera capabilities, positioning itself as a pioneer in software 3D camera technology. Dacuda aims to simplify 3D content creation, making it accessible to consumers through app-based scanning solutions. Its technology enables a range of applications, including enhanced user experiences for Augmented and Virtual Reality headsets. Additionally, Dacuda’s innovations include low-cost, real-time image processing that facilitates high-quality scans, effective text recognition, and the conversion of printed text or tables into editable digital formats, thereby streamlining data entry and content sharing. The company has received several prestigious awards for its contributions to technology and innovation.

Orcan Energy AG, founded in 2008 and based in Munich, Germany, specializes in developing, manufacturing, and selling energy solutions that convert waste heat into electricity using Organic Rankine Cycle (ORC) technology. The company's products, such as the PACK 20.30 and PACK 05.15 modules, are designed to reuse waste heat from various sources including industrial processes, traffic, and distributed energy conversion. These solutions have applications in marine, biogas, mobile applications like trucks, buses, construction machinery, and power generation. Orcan Energy's technology is known for its efficiency and ease of use, with innovations that make it suitable for mass market adoption. The company operates as a subsidiary of E.ON SE.

Sensimed AG is a medical devices company based in Lausanne, Switzerland, founded in 2003. The company specializes in the design, development, and commercialization of integrated micro-systems for medical applications, particularly focusing on glaucoma management. Its flagship product, the SENSIMED Triggerfish, is a soft, single-use contact lens that enables continuous monitoring of intraocular pressure (IOP) fluctuations in glaucoma patients over a 24-hour period. The Triggerfish system includes disposable sensors, an adhesive antenna for communication, a battery-powered recorder for data collection, and software for data management and analysis. Sensimed aims to enhance personalized treatment for glaucoma patients by analyzing the collected data to identify pathological patterns and improve clinical outcomes. The company's products are distributed through partners across Europe, Asia-Pacific, the Middle East, and the Americas. As of December 2019, Sensimed operates as a subsidiary of SEED Co., Ltd.

AYOXXA Biosystems GmbH is a life science tools company based in Cologne, Germany, with additional offices in Singapore and Boston, Massachusetts. Founded in 2010, AYOXXA specializes in developing a proprietary technology platform for multiplexed protein analysis. This platform, which utilizes In-situ Encoded Bead-based Arrays, enables users to simultaneously measure multiple protein markers associated with various health conditions, including cancer, allergies, cardiovascular diseases, and infectious diseases. AYOXXA's innovative biochips merge biological analysis with information technology, expanding the potential applications in biomedical research. The company also offers biomarker kits to facilitate the identification and quantification of proteins and other biomolecular analytes.

Readmill is a Berlin-based social reading platform that enables users to engage with ebooks in a collaborative manner. Founded by CEO Henrik Berggren, the platform allows individuals to highlight passages from their readings, share these highlights with friends, and initiate discussions about the content. Readmill has established partnerships with several independent bookstores, enhancing its offerings through collaborations with platforms such as Leanpub, Readlists, Free-ebooks.net, Jottify, OR Books, Publit, and Bibliocrunch. By fostering a community-oriented approach to reading, Readmill aims to enrich the reading experience and promote meaningful interactions around literature.

Bonusbox GmbH, established in 2011 and headquartered in Berlin, Germany, specializes in operating an online customer retention platform for merchants. This platform facilitates multi-partner loyalty networks, enabling merchants to attract new customers and retain existing ones through incentive schemes. By integrating seamlessly into merchants' websites, bonusbox allows customers to earn points with each purchase, which can be redeemed instantly for rewards or tracked alongside other purchases. The platform also provides merchants with valuable insights into customer behavior by structuring previously disparate data.

eWise is an international provider of personal financial management and account aggregation solutions, founded in 2000 and headquartered in Switzerland. The company specializes in developing financial service software that enables users to consolidate various financial accounts into a single interface while ensuring robust online security. eWise's Money Manager is utilized by innovative banks worldwide, including major institutions in Europe, Asia, America, and Australia. Their offerings include tools for online payment, account aggregation, security, authentication, and wealth management, catering to the needs of both consumers and financial institutions.

Sapiens Steering Brain Stimulation GmbH is a medical device company focused on advancing deep brain stimulation (DBS) therapy. Founded in 2011 as a spin-out of Royal Philips Electronics, Sapiens operates from offices in Eindhoven, the Netherlands, and Munich, Germany. The company is dedicated to developing a high-resolution, MRI-compatible DBS system designed to enhance patient comfort and improve therapeutic outcomes, particularly for individuals with Parkinson's disease. Sapiens’ innovative approach includes a unique steering brain stimulation system and image-guided programming, both of which are based on patented technologies.

Enecsys Limited is a company specializing in the development, manufacturing, and marketing of advanced solar micro inverters and monitoring systems. These products are designed to convert direct current (DC) from solar modules into clean alternating current (AC) for integration into the electricity grid. Enecsys micro inverters are known for their ability to maximize energy harvest, enhance safety, and provide improved reliability and performance monitoring. The company's monitoring system allows for real-time tracking of each photovoltaic module's performance through a robust wireless communication network that connects to the Internet. Headquartered in Cambridge, UK, Enecsys also maintains sales and support offices in Germany, the USA, and Taiwan, serving both residential and commercial markets.

Orcan Energy AG, founded in 2008 and based in Munich, Germany, specializes in developing, manufacturing, and selling energy solutions that convert waste heat into electricity using Organic Rankine Cycle (ORC) technology. The company's products, such as the PACK 20.30 and PACK 05.15 modules, are designed to reuse waste heat from various sources including industrial processes, traffic, and distributed energy conversion. These solutions have applications in marine, biogas, mobile applications like trucks, buses, construction machinery, and power generation. Orcan Energy's technology is known for its efficiency and ease of use, with innovations that make it suitable for mass market adoption. The company operates as a subsidiary of E.ON SE.

Experteer is a Munich-based online career and recruitment marketplace that specializes in high-end job opportunities across Europe. Founded in 2005, the platform features over 80,000 job listings targeted at experienced executives and senior professionals. Experteer provides access to a discreet network of more than 8,000 recruiters and 10,000 headhunters, facilitating connections to the hidden job market. The platform offers premium services that include personalized job recommendations, market insights, and salary benchmarks, all curated by a dedicated team of recruitment professionals. Additionally, Experteer serves as a resource for headhunters, providing job advertising and candidate sourcing solutions. Overall, Experteer aims to support candidates in managing their careers effectively while also connecting companies with top-tier talent.

AZZURRO Semiconductors AG is a semiconductor company based in Magdeburg, Germany, founded in 2003. The company specializes in manufacturing and marketing gallium nitride on silicon (GaN-on-Si) epitaxial wafers, which are essential for various applications including high voltage electronics, field-effect transistors (FETs), light-emitting diodes (LEDs), automotive components, and switching devices for power supplies. AZZURRO Semiconductors AG's products facilitate advancements in semiconductor development and are utilized in a range of technologies, including sensors. As of April 30, 2014, the company is undergoing liquidation.

mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec(R) Histology Kit and CINtec(R) Cytology Kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4(TM) antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results.

Experteer is a Munich-based online career and recruitment marketplace that specializes in high-end job opportunities across Europe. Founded in 2005, the platform features over 80,000 job listings targeted at experienced executives and senior professionals. Experteer provides access to a discreet network of more than 8,000 recruiters and 10,000 headhunters, facilitating connections to the hidden job market. The platform offers premium services that include personalized job recommendations, market insights, and salary benchmarks, all curated by a dedicated team of recruitment professionals. Additionally, Experteer serves as a resource for headhunters, providing job advertising and candidate sourcing solutions. Overall, Experteer aims to support candidates in managing their careers effectively while also connecting companies with top-tier talent.

eCircle is a provider of software and services for digital dialog marketing in Europe, specializing in email marketing solutions. Founded in 1999 and headquartered in Munich, Germany, the company operates additional offices in the United Kingdom, France, Spain, the Netherlands, and Italy. eCircle offers a range of products, including software for email and SMS broadcasting, as well as email address data for newsletter mailings and various marketing campaigns. In addition to its software offerings, eCircle provides consulting services to help clients optimize their marketing strategies, along with social media functionalities to enhance engagement.

EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building automation, industrial applications, and environmental monitoring. The company offers a range of products, including energy converters, wireless sensors, controllers, transmitters, receivers, and development tools, designed to enable maintenance-free, battery-less operations in various environments. EnOcean's innovative technology allows sensors to harvest energy from their surroundings, making them ideal for applications in smart homes, lighting systems, and automated meter reading. The company distributes its products through a network of partners across numerous countries, including Austria, Belgium, Canada, China, Germany, the United States, and several others in Europe and beyond. EnOcean's solutions aim to enhance energy efficiency and user convenience in the growing Internet of Things market.

Evolva is a biotechnology company based in Reinach, Switzerland, that specializes in the development and commercialization of nature-based ingredients and innovative small-molecule compounds. Founded in 2004, Evolva leverages a proprietary synthetic biology platform to create high-quality ingredients that serve various applications, including flavors, fragrances, health ingredients, and health protection. By mimicking the chemical structures found in natural products, Evolva's technology offers solutions that avoid the limitations associated with traditional methods, thus providing a versatile approach to ingredient formulation and product development.

Heliatek GmbH, founded in 2006 and based in Dresden, Germany, specializes in the development and manufacture of organic photovoltaics (OPV) solutions, particularly HeliaSol and HeliaFilm. These innovative products are designed for integration into various building surfaces, including horizontal, vertical, and curved structures, making them suitable for retrofitting existing buildings as well as for new construction. Heliatek's OPV technology is characterized by its ultra-lightweight and flexible nature, contributing to environmentally friendly energy solutions. The company serves a diverse clientele, including those in the building and construction materials industry, automotive manufacturers, and suppliers, and has established strategic partnerships with firms such as AGC Glass Europe and Reckli China. With approximately 160 employees, Heliatek is at the forefront of advancing organic electronics, utilizing advanced roll-to-roll manufacturing processes in controlled environments to produce its solar films.

Evolva is a biotechnology company based in Reinach, Switzerland, that specializes in the development and commercialization of nature-based ingredients and innovative small-molecule compounds. Founded in 2004, Evolva leverages a proprietary synthetic biology platform to create high-quality ingredients that serve various applications, including flavors, fragrances, health ingredients, and health protection. By mimicking the chemical structures found in natural products, Evolva's technology offers solutions that avoid the limitations associated with traditional methods, thus providing a versatile approach to ingredient formulation and product development.

Symetis is a Swiss company based in Ecublens that specializes in developing innovative minimally invasive heart valve replacement therapies. The company focuses on improving patient care and safety through its proprietary Acurate™ Aortic Valve Replacement System, which features a unique self-positioning design. This design allows for easier implant positioning and alignment, enhancing the overall user experience for healthcare providers. Symetis aims to address the needs of patients suffering from aortic valve stenosis, enabling the effective treatment of severe cardiac valve conditions through its advanced transcatheter aortic valve implantation devices.

Enecsys Limited is a company specializing in the development, manufacturing, and marketing of advanced solar micro inverters and monitoring systems. These products are designed to convert direct current (DC) from solar modules into clean alternating current (AC) for integration into the electricity grid. Enecsys micro inverters are known for their ability to maximize energy harvest, enhance safety, and provide improved reliability and performance monitoring. The company's monitoring system allows for real-time tracking of each photovoltaic module's performance through a robust wireless communication network that connects to the Internet. Headquartered in Cambridge, UK, Enecsys also maintains sales and support offices in Germany, the USA, and Taiwan, serving both residential and commercial markets.

EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building automation, industrial applications, and environmental monitoring. The company offers a range of products, including energy converters, wireless sensors, controllers, transmitters, receivers, and development tools, designed to enable maintenance-free, battery-less operations in various environments. EnOcean's innovative technology allows sensors to harvest energy from their surroundings, making them ideal for applications in smart homes, lighting systems, and automated meter reading. The company distributes its products through a network of partners across numerous countries, including Austria, Belgium, Canada, China, Germany, the United States, and several others in Europe and beyond. EnOcean's solutions aim to enhance energy efficiency and user convenience in the growing Internet of Things market.

GameDuell is a Berlin-based developer and provider of casual and social online games, boasting over 125 million registered players across various platforms. Established in 2003 by Kai Bolik, Michael Kalkowski, and Boris Wasmuth, the company offers a diverse portfolio of more than 70 games, primarily developed in-house. Their range includes digital card and board games, action arcade titles, and puzzle games, commonly played across the web, social networks, and mobile devices. Notable titles in their lineup include Fluffy, Maya Pyramid, Bubble Speed, Jungle Jewels, and classic games such as Hearts, Solitaire, and Pool. With a team of 210 experienced professionals, GameDuell is recognized as a significant player in the casual gaming sector within Western markets.

Sensimed AG is a medical devices company based in Lausanne, Switzerland, founded in 2003. The company specializes in the design, development, and commercialization of integrated micro-systems for medical applications, particularly focusing on glaucoma management. Its flagship product, the SENSIMED Triggerfish, is a soft, single-use contact lens that enables continuous monitoring of intraocular pressure (IOP) fluctuations in glaucoma patients over a 24-hour period. The Triggerfish system includes disposable sensors, an adhesive antenna for communication, a battery-powered recorder for data collection, and software for data management and analysis. Sensimed aims to enhance personalized treatment for glaucoma patients by analyzing the collected data to identify pathological patterns and improve clinical outcomes. The company's products are distributed through partners across Europe, Asia-Pacific, the Middle East, and the Americas. As of December 2019, Sensimed operates as a subsidiary of SEED Co., Ltd.

Innovative Silicon was founded to develop and commercialise Floating Body effect memory for SoC/MPU products used in diverse applications including handheld computers, games consoles, cellular communications devices, cameras. The company closed its first round of VC funding in 2003, completed its first 90nm megabit Z-RAM memory design in 2004 and its first 65nm designs in 2005. The company was founded in 2002 and is headquartered in Santa Clara, California with additional offices in Lausanne, Switzerland; and Yokohama, Japan.

Experteer is a Munich-based online career and recruitment marketplace that specializes in high-end job opportunities across Europe. Founded in 2005, the platform features over 80,000 job listings targeted at experienced executives and senior professionals. Experteer provides access to a discreet network of more than 8,000 recruiters and 10,000 headhunters, facilitating connections to the hidden job market. The platform offers premium services that include personalized job recommendations, market insights, and salary benchmarks, all curated by a dedicated team of recruitment professionals. Additionally, Experteer serves as a resource for headhunters, providing job advertising and candidate sourcing solutions. Overall, Experteer aims to support candidates in managing their careers effectively while also connecting companies with top-tier talent.

Heliatek GmbH, founded in 2006 and based in Dresden, Germany, specializes in the development and manufacture of organic photovoltaics (OPV) solutions, particularly HeliaSol and HeliaFilm. These innovative products are designed for integration into various building surfaces, including horizontal, vertical, and curved structures, making them suitable for retrofitting existing buildings as well as for new construction. Heliatek's OPV technology is characterized by its ultra-lightweight and flexible nature, contributing to environmentally friendly energy solutions. The company serves a diverse clientele, including those in the building and construction materials industry, automotive manufacturers, and suppliers, and has established strategic partnerships with firms such as AGC Glass Europe and Reckli China. With approximately 160 employees, Heliatek is at the forefront of advancing organic electronics, utilizing advanced roll-to-roll manufacturing processes in controlled environments to produce its solar films.

Adviqo Group, established in 2000 and based in Berlin, Germany, is a leading media organization specializing in live counseling services tailored for female audiences. It operates a diverse portfolio that includes TV channels, online marketplaces, eCommerce sites, websites, and mobile applications, focusing on life advice, therapeutic counseling, and coaching. The company has a significant presence across five countries—Germany, the UK, France, Spain, and Poland—employing over 350 staff members. Adviqo is recognized as an exclusive content partner for prominent women's magazines and major online platforms, enhancing its reach and influence. With a strong management team drawn from various reputable firms and supported by notable investors, Adviqo has consistently achieved high double-digit revenues and maintained profitability.

Ingent Inc., a Germany-based provider of information retrieval infrastructure technologies for computer applications.

mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec(R) Histology Kit and CINtec(R) Cytology Kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4(TM) antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results.

VoiceObjects AG operates as a phone application server company. Its products include VoiceObjects Server, a phone application server that enables carrier-grade deployment and management of over-the-phone voice, video, text, and mobile Web self-service applications; and VoiceObjects Desktop, a GUI-based application for creating, testing, deploying, and monitoring self-service phone portals. The company also offers professional services, including consulting, training, and technical support services. Its customers include banking and financial services, communication, marketing agencies, industrial, travel and support, healthcare, government, entertainment and info-portals, and management service providers in the United States and internationally. The company has strategic partnerships with Alcatel, aperto move, Avaya, BEA, BusinessObjects, Cirquent GmbH, D+S solutions, EXCELSIS, Hermes SoftLab, Hewlett Packard, NextiraOne, Quinary, Sabio, Telenet GmbH, Unisys, and Voxeo. The company was formerly known as OneBridge AG and changed its name to VoiceObjects AG in July 2002. The company was founded in 2001 and is based in Bergisch Gladbach, Germany. As of December 9, 2008, VoiceObjects AG operates as a subsidiary of Voxeo Corporation.

XING Is the social network for business professionals. More than 13 million members worldwide – over 6.5 million of whom are based in german-speaking countries – use xing to boost their business, job, and career. Xing is a platform where professionals from all kinds of different industries can meet up, find jobs, colleagues, new assignments, cooperation partners, experts and generate business ideas. Members can meet and exchange views in over 50,000 specialist groups, while also getting together at networking events. The platform is operated by xing ag, which was founded in hamburg, germany, in 2003, has been publicly listed since 2006, and listed on the tecdax since september 2011. In december 2010, xing acquired amiando ag, a munich-based company and europe’s leading provider of online event management and ticketing. The acquisition of kununu gmbh, the leading platform for employer reviews in german-speaking countries, allows xing to extend its position as the social recruiting market leader.

VoiceObjects AG operates as a phone application server company. Its products include VoiceObjects Server, a phone application server that enables carrier-grade deployment and management of over-the-phone voice, video, text, and mobile Web self-service applications; and VoiceObjects Desktop, a GUI-based application for creating, testing, deploying, and monitoring self-service phone portals. The company also offers professional services, including consulting, training, and technical support services. Its customers include banking and financial services, communication, marketing agencies, industrial, travel and support, healthcare, government, entertainment and info-portals, and management service providers in the United States and internationally. The company has strategic partnerships with Alcatel, aperto move, Avaya, BEA, BusinessObjects, Cirquent GmbH, D+S solutions, EXCELSIS, Hermes SoftLab, Hewlett Packard, NextiraOne, Quinary, Sabio, Telenet GmbH, Unisys, and Voxeo. The company was formerly known as OneBridge AG and changed its name to VoiceObjects AG in July 2002. The company was founded in 2001 and is based in Bergisch Gladbach, Germany. As of December 9, 2008, VoiceObjects AG operates as a subsidiary of Voxeo Corporation.

Collax GmbH, founded in 2005 and based in Ismaning, Germany, specializes in developing Linux-based server solutions tailored for small to medium-sized enterprises. The company offers a range of products, including the Collax Business Server for network management, the Collax OX Server for information exchange, and the Collax Security Gateway for unified threat management. Collax’s solutions encompass various aspects of IT infrastructure, including network security, data management, email, collaboration, and web services, all designed to enhance productivity while ensuring robust security. With additional offices in Munich and Boston, Collax aims to provide adaptable and stable IT environments that support the growth of its clients' businesses.

EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building automation, industrial applications, and environmental monitoring. The company offers a range of products, including energy converters, wireless sensors, controllers, transmitters, receivers, and development tools, designed to enable maintenance-free, battery-less operations in various environments. EnOcean's innovative technology allows sensors to harvest energy from their surroundings, making them ideal for applications in smart homes, lighting systems, and automated meter reading. The company distributes its products through a network of partners across numerous countries, including Austria, Belgium, Canada, China, Germany, the United States, and several others in Europe and beyond. EnOcean's solutions aim to enhance energy efficiency and user convenience in the growing Internet of Things market.

VoiceObjects AG operates as a phone application server company. Its products include VoiceObjects Server, a phone application server that enables carrier-grade deployment and management of over-the-phone voice, video, text, and mobile Web self-service applications; and VoiceObjects Desktop, a GUI-based application for creating, testing, deploying, and monitoring self-service phone portals. The company also offers professional services, including consulting, training, and technical support services. Its customers include banking and financial services, communication, marketing agencies, industrial, travel and support, healthcare, government, entertainment and info-portals, and management service providers in the United States and internationally. The company has strategic partnerships with Alcatel, aperto move, Avaya, BEA, BusinessObjects, Cirquent GmbH, D+S solutions, EXCELSIS, Hermes SoftLab, Hewlett Packard, NextiraOne, Quinary, Sabio, Telenet GmbH, Unisys, and Voxeo. The company was formerly known as OneBridge AG and changed its name to VoiceObjects AG in July 2002. The company was founded in 2001 and is based in Bergisch Gladbach, Germany. As of December 9, 2008, VoiceObjects AG operates as a subsidiary of Voxeo Corporation.

EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building automation, industrial applications, and environmental monitoring. The company offers a range of products, including energy converters, wireless sensors, controllers, transmitters, receivers, and development tools, designed to enable maintenance-free, battery-less operations in various environments. EnOcean's innovative technology allows sensors to harvest energy from their surroundings, making them ideal for applications in smart homes, lighting systems, and automated meter reading. The company distributes its products through a network of partners across numerous countries, including Austria, Belgium, Canada, China, Germany, the United States, and several others in Europe and beyond. EnOcean's solutions aim to enhance energy efficiency and user convenience in the growing Internet of Things market.

mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec(R) Histology Kit and CINtec(R) Cytology Kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4(TM) antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results.

WLAN AG is a wireless local area network distributor. It focuses on the professional client support with regard to evaluation, planning, implementation, operation, and support of WLAN and network access control solutions. It offers its users with network engineering, operations, troubleshooting, and WLAN engineering services. The company offers solutions for network access controlling, public transport systems, and public WLAN. WLAN AG is a Switzerland-based company that was founded in 2004. The company was acquired by Swisscom Eurospot on March 7, 2003.

EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building automation, industrial applications, and environmental monitoring. The company offers a range of products, including energy converters, wireless sensors, controllers, transmitters, receivers, and development tools, designed to enable maintenance-free, battery-less operations in various environments. EnOcean's innovative technology allows sensors to harvest energy from their surroundings, making them ideal for applications in smart homes, lighting systems, and automated meter reading. The company distributes its products through a network of partners across numerous countries, including Austria, Belgium, Canada, China, Germany, the United States, and several others in Europe and beyond. EnOcean's solutions aim to enhance energy efficiency and user convenience in the growing Internet of Things market.

eCircle is a provider of software and services for digital dialog marketing in Europe, specializing in email marketing solutions. Founded in 1999 and headquartered in Munich, Germany, the company operates additional offices in the United Kingdom, France, Spain, the Netherlands, and Italy. eCircle offers a range of products, including software for email and SMS broadcasting, as well as email address data for newsletter mailings and various marketing campaigns. In addition to its software offerings, eCircle provides consulting services to help clients optimize their marketing strategies, along with social media functionalities to enhance engagement.